Arquer, Euro Diagnostica agreement, 4/16
April 2016—Arquer Diagnostics has signed an agreement with Euro Diagnostica for the manufacturing and supply of Arquer’s Mcm5-ELISA test for the diagnosis of bladder cancer.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Flow cytometer, 4/16
April 2016—The BD FACSCelesta flow cytometer is designed to make multicolor flow cytometry more accessible and allow researchers to benefit from innovations in instrument and reagent technology.
Detection test for Zika virus, 4/16
April 2016—Siemens Healthcare Diagnostics plans to release a genetic assay designed to test for the presence of the Zika virus.
Hardy Diagnostics acquires GG&B, 4/16
April 2016—Hardy Diagnostics announced the acquisition of Wichita Falls, Tex.-based GG&B Company, maker of automated microscope slide stainers for laboratory use.
Targeted RNA panels for NGS, 4/16
April 2016—Qiagen introduced more than 170 new QIAseq Targeted RNA Panels for gene expression profiling.
Digoxigenin-labeled nucleotides, 4/16
April 2016—Enzo Life Sciences now offers Digoxigenin-dUTP and Digoxigenin-UTP, digoxigenin-labeled nucleotides that are suitable for a variety of molecular biology applications.
Neurodevelopmental genetic tests, 3/16
March 2016—Ambry Genetics has launched a suite of five genetic tests for neurodevelopmental conditions: IDNext, a broad panel of 140 genes known to be associated with both syndromic and nonsyndromic intellectual disability; AutismFirst, a targeted panel of 16 genes recognized by the American College of Genetics and Genomics as associated with syndromic
Hydraulic cadaver carrier, 3/16
March 2016—Mopec has developed a powered hydraulic cadaver carrier capable of transporting up to 700 pounds with a simple light touch. Powered by a battery-operated motorized base, the Mopec JA800 Powered Hydraulic Cadaver Carrier easily navigates corners, ramps, and doors as it safely moves without manual force, allowing even small operators to transport effortlessly, free from back and body strain.
Bio-Rad, Illumina partnership, 3/16
March 2016—Bio-Rad Laboratories and Illumina announced an exclusive partnership to develop a comprehensive next-generation sequencing workflow for single-cell analysis. The end-to-end commercial solution will enable high-throughput sequencing of thousands of individual cells.
Benchtop centrifuge, 3/16
March 2016—The Thermo Scientific Medifuge is a benchtop centrifuge that features a two-in-one hybrid rotor with interchangeable fixed-angle and swinging buckets to facilitate quick and convenient switching between applications. When coupled with the Thermo Scientific DualSpin rotor, the centrifuge provides the flexibility to perform several applications on a single platform.